← Evidence map

TrialCell reports. Medicine2021

Molecular predictors of response to pembrolizumab in thymic carcinoma.

Yongfeng He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34622229